Annual CFI
$0.00
+$114.00 K+100.00%
31 December 2023
Summary:
Akebia Therapeutics annual cash flow from investing activities is currently $0.00, with the most recent change of +$114.00 thousand (+100.00%) on 31 December 2023. During the last 3 years, it has risen by +$40.00 million (+100.00%). AKBA annual CFI is now -100.00% below its all-time high of $211.18 million, reached on 31 December 2019.AKBA Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$2000.00
+$27.00 K+93.10%
30 September 2024
Summary:
Akebia Therapeutics quarterly cash flow from investing activities is currently -$2000.00, with the most recent change of +$27.00 thousand (+93.10%) on 30 September 2024. Over the past year, it has dropped by -$2000.00 (-100.00%). AKBA quarterly CFI is now -100.00% below its all-time high of $110.47 million, reached on 31 March 2019.AKBA Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$31.00 K
-$2000.00-6.90%
30 September 2024
Summary:
Akebia Therapeutics TTM cash flow from investing activities is currently -$31.00 thousand, with the most recent change of -$2000.00 (-6.90%) on 30 September 2024. Over the past year, it has dropped by -$31.00 thousand (-100.00%). AKBA TTM CFI is now -100.01% below its all-time high of $211.18 million, reached on 31 December 2019.AKBA TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AKBA Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +100.0% | -100.0% | -100.0% |
| 3 y3 years | +100.0% | -100.0% | -100.0% |
| 5 y5 years | -100.0% | -100.0% | -100.0% |
AKBA Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -100.0% | +100.0% | +98.3% | -100.0% | +72.8% | |
| 5 y | 5 years | -100.0% | +100.0% | -100.0% | +100.0% | -100.0% | +100.0% |
| alltime | all time | -100.0% | +100.0% | -100.0% | +100.0% | -100.0% | +100.0% |
Akebia Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$2000.00(-93.1%) | -$31.00 K(+6.9%) |
| June 2024 | - | -$29.00 K(<-9900.0%) | -$29.00 K(<-9900.0%) |
| Mar 2024 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2023 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2023 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2023 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2023 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Dec 2022 | -$114.00 K(-100.3%) | $0.00(0.0%) | -$114.00 K(0.0%) |
| Sept 2022 | - | $0.00(0.0%) | -$114.00 K(0.0%) |
| June 2022 | - | $0.00(-100.0%) | -$114.00 K(-100.6%) |
| Mar 2022 | - | -$114.00 K(<-9900.0%) | $19.89 M(-50.2%) |
| Dec 2021 | $39.94 M(-199.8%) | $0.00(0.0%) | $39.94 M(-59.9%) |
| Sept 2021 | - | $0.00(-100.0%) | $99.62 M(+100.5%) |
| June 2021 | - | $20.00 M(+0.3%) | $49.69 M(-344.7%) |
| Mar 2021 | - | $19.94 M(-66.6%) | -$20.31 M(-49.2%) |
| Dec 2020 | -$40.00 M(-118.9%) | $59.68 M(-219.5%) | -$40.00 M(-48.3%) |
| Sept 2020 | - | -$49.94 M(-0.1%) | -$77.41 M(+2413.2%) |
| June 2020 | - | -$49.99 M(<-9900.0%) | -$3.08 M(-103.1%) |
| Mar 2020 | - | $245.00 K(-98.9%) | $100.95 M(-52.2%) |
| Dec 2019 | $211.18 M(+477.1%) | $22.28 M(-8.7%) | $211.18 M(+2.7%) |
| Sept 2019 | - | $24.39 M(-54.9%) | $205.61 M(+7.0%) |
| June 2019 | - | $54.03 M(-51.1%) | $192.23 M(+42.8%) |
| Mar 2019 | - | $110.47 M(+560.8%) | $134.63 M(+267.9%) |
| Dec 2018 | $36.59 M | $16.72 M(+51.8%) | $36.59 M(+216.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2018 | - | $11.01 M(-408.6%) | $11.57 M(-126.1%) |
| June 2018 | - | -$3.57 M(-128.7%) | -$44.40 M(-38.8%) |
| Mar 2018 | - | $12.43 M(-249.7%) | -$72.52 M(-59.1%) |
| Dec 2017 | -$177.26 M(-1495.2%) | -$8.31 M(-81.5%) | -$177.26 M(+20.9%) |
| Sept 2017 | - | -$44.96 M(+41.9%) | -$146.65 M(+161.3%) |
| June 2017 | - | -$31.69 M(-65.7%) | -$56.12 M(-1147.6%) |
| Mar 2017 | - | -$92.30 M(-513.8%) | $5.36 M(-57.8%) |
| Dec 2016 | $12.71 M(-192.8%) | $22.31 M(-51.0%) | $12.71 M(-259.6%) |
| Sept 2016 | - | $45.57 M(+53.0%) | -$7.96 M(-88.3%) |
| June 2016 | - | $29.79 M(-135.1%) | -$67.98 M(-33.4%) |
| Mar 2016 | - | -$84.95 M(-5286.5%) | -$102.05 M(+645.5%) |
| Dec 2015 | -$13.69 M(-79.1%) | $1.64 M(-111.3%) | -$13.69 M(-40.4%) |
| Sept 2015 | - | -$14.46 M(+238.0%) | -$22.96 M(-52.7%) |
| June 2015 | - | -$4.28 M(-225.6%) | -$48.51 M(-27.9%) |
| Mar 2015 | - | $3.40 M(-144.6%) | -$67.31 M(+3.0%) |
| Dec 2014 | -$65.35 M(+472.0%) | -$7.64 M(-80.9%) | -$65.35 M(+16.7%) |
| Sept 2014 | - | -$40.00 M(+73.3%) | -$55.98 M(+92.1%) |
| June 2014 | - | -$23.07 M(-530.7%) | -$29.14 M(+380.3%) |
| Mar 2014 | - | $5.36 M(+208.8%) | -$6.07 M(-46.9%) |
| Dec 2013 | -$11.43 M(-936.4%) | $1.74 M(-113.2%) | -$11.43 M(-13.2%) |
| Sept 2013 | - | -$13.16 M(<-9900.0%) | -$13.16 M(<-9900.0%) |
| June 2013 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2013 | - | $0.00 | $0.00 |
| Dec 2012 | $1.37 M | - | - |
FAQ
- What is Akebia Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Akebia Therapeutics?
- What is Akebia Therapeutics annual CFI year-on-year change?
- What is Akebia Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Akebia Therapeutics?
- What is Akebia Therapeutics quarterly CFI year-on-year change?
- What is Akebia Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Akebia Therapeutics?
- What is Akebia Therapeutics TTM CFI year-on-year change?
What is Akebia Therapeutics annual cash flow from investing activities?
The current annual CFI of AKBA is $0.00
What is the all time high annual CFI for Akebia Therapeutics?
Akebia Therapeutics all-time high annual cash flow from investing activities is $211.18 M
What is Akebia Therapeutics annual CFI year-on-year change?
Over the past year, AKBA annual cash flow from investing activities has changed by +$114.00 K (+100.00%)
What is Akebia Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of AKBA is -$2000.00
What is the all time high quarterly CFI for Akebia Therapeutics?
Akebia Therapeutics all-time high quarterly cash flow from investing activities is $110.47 M
What is Akebia Therapeutics quarterly CFI year-on-year change?
Over the past year, AKBA quarterly cash flow from investing activities has changed by -$2000.00 (-100.00%)
What is Akebia Therapeutics TTM cash flow from investing activities?
The current TTM CFI of AKBA is -$31.00 K
What is the all time high TTM CFI for Akebia Therapeutics?
Akebia Therapeutics all-time high TTM cash flow from investing activities is $211.18 M
What is Akebia Therapeutics TTM CFI year-on-year change?
Over the past year, AKBA TTM cash flow from investing activities has changed by -$31.00 K (-100.00%)